Ying Luo Reports 8.54% Stake in Gyre Therapeutics as of September 6- SEC Filing
尤瑞公司報告稱,截至9月6日,羅英持有Gyre Therapeutics 8.54%的股份-SEC文件
Ying Luo Reports 8.54% Stake in Gyre Therapeutics as of September 6- SEC Filing
尤瑞公司報告稱,截至9月6日,羅英持有Gyre Therapeutics 8.54%的股份-SEC文件
譯文內容由第三人軟體翻譯。